Brown Advisory’s Twist Bioscience TWST Stock Holding History

Brown Advisory’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-6,095	Closed	-$225K	–	1292
2023 Q4	$225K	Buy	+6,095	New	+$141K	﹤0.01%	1132

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Brown Advisory's TWST Position: Q1 2024 in Review

Brown Advisory sold out of Twist Bioscience (TWST) in Q1 2024, closing a stake of 6,095 shares — an estimated $225K sold.

Brown Advisory first reported a position in TWST in Q4 2023 and held it in 1 quarter. The position peaked at $225K in Q4 2023. 237 funds tracked by Wall St. Rank hold TWST as of Q1 2024.

Brown Advisory reported no remaining Twist Bioscience position as of Q1 2024 after selling out during the quarter.
Brown Advisory sold 6,095 Twist Bioscience shares in Q1 2024, an estimated $225K.
Brown Advisory first reported a position in Twist Bioscience in Q4 2023 and held it in 1 quarter.
Brown Advisory's Twist Bioscience position peaked at $225K in Q4 2023.
237 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2024.

Based on Brown Advisory's 13F filing for Q1 2024, filed 24 Apr 2024.